Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lineage Cell Therapeutics Inc. Director's Dealing 2021

May 6, 2021

6895_dirs_2021-05-06_a3ed491c-77c5-40ef-96ba-784311d1eb10.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Lineage Cell Therapeutics, Inc. (LCTX)
CIK: 0000876343
Period of Report: 2021-05-04

Reporting Person: Jayasuriya Anula (Director)

More from Lineage Cell Therapeutics Inc.

Report Publication Announcement 2026
May 13
Interim / Quarterly Report 2026
May 13
Earnings Release 2026
May 13
Report Publication Announcement 2026
May 13
Report Publication Announcement 2026
May 13
Interim / Quarterly Report 2026
May 12
Regulatory Filings 2026
May 12
Report Publication Announcement 2026
May 5
Earnings Release 2026
May 5
Investor Presentation 2026
May 4
View all filings →